Stockreport

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Insulet Corporation  (PODD) 
Last insulet corporation earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.insulet.com/investor-relations
PDF Conducted in the United States and France, the OP5-003 Trial is the first Omnipod 5 study to include international participants.The OP5-003 Trial Presentation and Insule [Read more]